ISSN: 2688-8203
Managing Editor: Julia Vinscent
Contact us at:
2011-2016 Resident ，Department of Oncology, Xijing Hospital, Air Force Military Medical University 2022-Present Attending physician, Department of Radiation Oncology, Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College July 2016 – July 2019: Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Research areas: Cohort study of radical resection combined with intraoperative radiotherapy for centrally located hepatocellular carcinoma Molecular biological characteristics and clinical significance of recurrent thymoma A cohort study of breast-conserving surgery combined with intraoperative radiotherapy for breast cancer To investigate the clinical application of mobile intraoperative radiotherapy accelerator in the treatment of malignant tumors August 2019 – July 2022: Sun Yat-sen University Cancer Center Research areas: Multicenter phase III study of sintilimab in induction and concurrent treatment of nasopharyngeal carcinoma Multi-center phase III study of camrelizumab in the adjuvant treatment of nasopharyngeal carcinoma. A single-center phase II study of concurrent chemotherapy screening for intermediate-risk nasopharyngeal carcinoma To investigate the role and mechanism of miR-16 in the proliferation and metastasis of nasopharyngeal carcinoma TRIM21 regulates radiotherapy-induced anti-tumor immune response in nasopharyngeal carcinoma via G3BP1 August 2022 – Present: Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
nasopharyngeal carcinoma，head and neck cancer (Tumors of the head, face, mouth, throat, neck, etc.)
Dr. Nezami is an MD graduate of USC and UCSF internship and residencies. He has been in practice for 21 years and currently is the president of Orange Coast Medical Center of Hope in California .He serves as national and international speaker in oncology and epigenetic science. He has been involved in many research projects, presentations and publications.
Oncology and Epigenetics
Oncology
Allen Movahed, who speaks five languages, received clinical post doctorate training in medical radiation therapy physics at the University of Oklahoma in 2004. Prior to that, he earned a doctorate of philosophy degree in medical physics from the Cancer Institute of Madras at the University of Madras, respectively. While at the Cancer Institute of Madras, He was involved in pioneering work on bone scanning application for treating patients with breast cancer. He has more than 26 years of experience in the fields of medical physics, including nuclear medicine, radiology, radiation oncology, and radiation protection. He served on the faculty and taught medical physics to graduate students and radiology residents at the University of Oklahoma Health Sciences Center and at medical science universities in Tehran, Iran. He is accomplished in the private sector, as well, having worked for GAMMEX RMI, under close collaboration with the University of Wisconsin, Madison. He excelled in implementing creative ideas for measuring tools that allowed for improved functioning and delivery of radiation treatment. He has been focused on delivery of radiation therapy to cancer patients. He has presented his work at conferences and meetings for the International Organization for Medical Physics, the American Association of Physicists in Medicine, the American Society for Therapeutic Radiology and Oncology and the Journal of Applied Clinical Medical Physics. In 2008, his work on TomoTherpay was selected as the science highlights of 50th AAPM meeting in Houston.
Radiation Oncologist
Oncology, Hematologic Disorders & Genetics
Oncology
Oncology
Alain L Fymat is a medical-physical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center.
Cancer, Parkinsons and Alzheimers Diseases
Clinical scale immune cells preparation, Primary tumor lines establishment, Molecular biology and flow cytometry, Pre-clinical murine tumor bearing models
Oncology, Cancer
Precision and personalized multiple disciplinary therapy model of colorectal cancer and molecular mechanism of tumor metastasis
Cancer and Immunity
Radiology
Oncological Nutrition
Oncology
Gianluca Franceschini is top level senior physician at the operating unit of Breast Surgery, relating to the Woman and Child Health Area Womans Health Section, at the Catholic University of the Sacred Heart Polyclinic Foundation Agostino Gemelli, Rome. He is an Assistant Professor since 1 st June 2006, by decree of the Rector Magnificus for the scientific field MED/18 GENERAL SURGERY, awarded to the Institute of Surgical Semiotics at the Catholic University of the Sacred Heart in Rome. Eligible to second grade professor in the scientific medical branch 06/C1 Notification 2012 DD n. 222/2012 ASN NATIONAL Scientific Qualification 2012 MIUR. In charge of the ordinary operating unit for integrated therapies for Breast Cancer at the Woman and Child Health Area Womans Health Section, at the Catholic University of the Sacred Heart Polyclinic Agostino Gemelli, Rome, since 1 st July 2014
Oncological Surgery
Andrew Hague’s interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world. In 2016, Professor Hague devised the protocol for curing cancer and this is now used in CellSonic Clinics in India, Peru, Switzerland and Poland. Many more are planned. There are no side effects, drugs must not be used and the cancer is stopped within three days.
Tissue regeneration, Cancer - diagnosis and treatment Diabetes
Cancer
Gynecology
Wagner Loyola holds a bachelors degree in biomedicine from the State University of Londrina (1987),a masters degree in Microbiology from the State University of Londrina (2001)and a doctorate in microbiology from the State University of Londrina (2007). He currently holds the position of researcher in the area of Immunology at Embrapa pigs and chickens in Concordia, Brazil. He acted as professor of immunology at the State University of Northern Parana. Acted as external advisor; ad hoc; at the State University of Londrina in extension projects. He has experience in Immunology, with emphasis in Cellular Immunology, working mainly in the following subjects: macrophages, concanavalin a, public health, animal health, neutrophils and phagocytic cells.
Immunology
Pediatric oncology, Breast cancer, Gastrointestinal cancers, Head and neck cancers and particularly nasopharyngeal cancer
Razvan Hainarosie is working in the most important surgical center from Romania in the field of otorhinolaryngology and Head and Neck Surgery. They had done more than 230 beds dedicated to ENT and Head and Neck Surgery, an operating theater with 9 surgical theaters, and more than 50 surgeries per day. His activity is concerning mainly head and neck oncology, rhinology, anterior skull base surgery (endoscopic and external), laryngology including LASER surgery. He is passionate about new surgical technologies.
Head and Neck oncology
Cheepsattayakorn graduated Doctor of Medicine from Chiang Mai Medical School, Chiang Mai University, Chiang Mai, Thailand in 1986. He then further had trained in Internal Medicine, Pulmonology, and Radiology at Chiang Mai University Medical School. He certified numerous Fellowships from the Royal Colleges of Physicians of London, Edinburgh and Thailand, Royal College of Physicians and Surgeons of Glasgow, American College of Physicians, and American College of Chest Physicians. He has very high experience in the fields of Pulmonary Diseases and Tuberculosis including Infectious Diseases. He had been served a Director of the 10th Zonal Tuberculosis and Chest Diseases Center, Chiang Mai, Thailand for a long time and presently serve as Consultant in Respiratory Medicine (Pulmonologist) at the 10th Zonal Tuberculosis and Chest Diseases Center, Chiang Mai, Thailand. Director and Senior Expert of the 5th Office of Disease Prevention and Control, Rachaburi, Thailand, Department of Disease Control, Ministry of Public Health, Thailand.
Novel Therapeutics in Lung Cancer, Human Genetics and Infectious Diseases
Immunotherapy & cancer
Oncology
Kaushal Kishor Prasad (KKP) is Professor & Chief of the Division of Gastrointestinal Histopathology in the Department of Super speciality of Gastroenterology at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. KKP has modified the Marsh-Oberhuber classification of celiac disease, developed the grading system of histological lesions in celiac disease; histological scoring and grading system of lesions in ulcerative colitis; coined the term Follicular esophagitis for a novel histopathological entity in esophagus and developed the rice based gluten-free composite flour cookies for celiac disease patients. He has received 31 awards in international and national scientific forums including V R Khanolkar and S R Naik award. He is also iconic achiever for The International Plato Award for Educational Achievement, International Hippocrates Award for Medical Achievement, Da Vinci Diamond For Inspirational Accomplishment etc.
Celiac Disease, Microscopic Colitis, Extrahepatic Portal Vein Obstruction and Inflammatory Bowel Disease
Pankaj Srivastava is a consultant surgeon in Om Surgical Center, Varanasi, India. He is doing all kind of Laparoscopic abdominal and gynecologic surgeries, breast surgery but his main thrust is thoracic, thoracoscopic surgery and VATS. He is doing thoracic decortications, lung and thoracic tumor surgeries. He is dealing with lung malignancy too. He is deeply engaged in critical care services in his hospital and did many thoracic procedures under critical anesthesia.He did his graduation from GSVM medical college, Kanpur in 1997 and postgraduation from Institute of medical sciences, BHU in 2002. He is a keen researcher and is actively engaged in many clinical trials and drug development programme. He was Senior Research Fellow of Indian council of medical research from 2000-2004, in which he did research on polyherbal formulation in biliary stone diseases. He had undergone specialized laparoscopic & thoracoscopic surgery training in 2004 from Indraprasth Apollo Hospital, New Delhi and AdvancedOpen Thoracic, Thoracoscopic, VATS & Robotic Surgery training in 2013 from Sir Ganga Ram Hospital, New Delhi.
Gastroenterology and Hepatology ,Clinical Drug Trials,Lap Abdominal & Gynecologic Surgery
a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com.
Best viewed in
| Above IE 9.0 version | Privacy Policy
